• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Development deals

robotics robots smart facility automation automated process
Manufacturing

Astellas, Yaskawa unite for robotic cell therapy production JV

Astellas Pharma and Yaskawa Electric Corporation are going in on a joint venture to develop an automated cell therapy production system.
Joseph Keenan Mar 7, 2025 3:35pm
Cancer cells

Mayo, InSitu pen prolonged-release cancer co-development pact

Jan 3, 2023 7:15am
DNA helix forming inside a test tube

Selecta taps Ginkgo to improve gene therapy delivery 

Jan 11, 2022 9:40am
Eye

Iacta bags rights to Tallc's pan-ocular drug delivery technology

Dec 21, 2021 8:55am
Handshake

Seelos eyes chronic ketamine dosing with sublingual candidate

Nov 30, 2021 9:45am
Takeda HQ

Takeda, JCR ink deal to commercialize Hunter syndrome drug

Sep 30, 2021 10:35am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings